Chilean Good Manufacturing Practices
Chile's technical standard on Good Manufacturing Practices for human-use medicines (Norma Técnica N° 127), originally approved by Decreto Exento N° 28 of 2012 and updated by Decreto Exento N° 159 of 2013, under the pharmaceutical control regulation (DS N° 3 of 2010). It is grounded in WHO GMP (Reports 32/33, updated per Report 37) and enforced by the Instituto de Salud Pública (ANAMED).
What this does not cover
stated in the document's own scope- Covers GMP for medicines for human use; other product classes follow their own Chilean technical standards.
- Sets manufacturing GMP, not the marketing-registration decision, which the ISP handles under the pharmaceutical-control regulation.
- Establishes the GMP requirement, not the analytical test methods, which derive from the applicable pharmacopoeia.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
Norma Técnica N° 127 is Chile’s technical standard on Good Manufacturing Practices for medicines for human use. It was originally approved by Decreto Exento N° 28 of 2012 and updated by Decreto Exento N° 159 of 2013, operating under the pharmaceutical-control regulation set by Decreto Supremo N° 3 of 2010. The standard is grounded in WHO GMP guidance (the 32nd and 33rd reports of the WHO Expert Committee, updated in line with its 37th report) and sets the manufacturing quality requirements a producer must meet. It is enforced by the Instituto de Salud Pública through its medicines agency ANAMED.
Scope & applicability
Laboratories and manufacturers of human-use medicines for the Chilean market. The ISP inspects facilities, equipment, and records against Norma Técnica N° 127 and certifies GMP compliance.
Legal basis & how it acquires force
The standard acquires force through Chilean decree: Decreto Exento N° 159 of 2013 approves the updated Norma Técnica, and it sits under the binding pharmaceutical-control framework of Decreto Supremo N° 3 of 2010 (the National Regulation on Pharmaceutical Products for Human Use). So the legal obligation is the Chilean regulation, with the Norma Técnica supplying the detailed GMP requirements. The Instituto de Salud Pública (ISP), through its Agencia Nacional de Medicamentos (ANAMED), is the authority that authorises manufacturers and verifies GMP compliance.
Document structure
| Part | Covers |
|---|---|
| Quality management | The quality system and quality-unit responsibilities |
| Personnel and hygiene | Organisation, training, and personnel hygiene |
| Premises and equipment | Design, qualification, and maintenance of facilities and equipment |
| Documentation | The documentation system, master and batch records, and data controls |
| Production and quality control | Manufacturing operations, in-process control, and the quality-control laboratory |
| Validation and self-inspection | Process and cleaning validation, self-inspection, and contracted activities |
Key requirements
- Comply with the WHO-based GMP requirements of Norma Técnica N° 127
- Maintain qualification, validation, and quality-control documentation
- Pass ISP on-site GMP inspection
Implementation tips
- Work from the Decreto Exento N° 159/2013 update of Norma Técnica N° 127
Revision notes
Approved by Decreto Exento N° 28 (2012) and updated by Decreto Exento N° 159 (2013), under DS N° 3/2010.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
Norma Técnica N° 127 is grounded in WHO Good Manufacturing Practices — the 32nd and 33rd reports of the WHO Expert Committee, updated per its 37th report — so Chile’s requirements track the WHO GMP reference text that many national authorities adopt directly. This keeps Chilean GMP broadly comparable with the international baseline, while the binding obligation remains the Chilean decree applied by the ISP/ANAMED.
Norma Técnica N° 127: frequently asked questions
Quick answers to common questions about Norma Técnica N° 127.
Which decree approves Chile’s GMP standard?
Norma Técnica N° 127 was originally approved by Decreto Exento N° 28 of 2012 and updated by Decreto Exento N° 159 of 2013, under the pharmaceutical-control regulation of Decreto Supremo N° 3 of 2010.
What is Chile’s GMP standard based on?
It is grounded in WHO Good Manufacturing Practices — the 32nd and 33rd reports of the WHO Expert Committee, updated in line with its 37th report.
Who enforces GMP in Chile?
The Instituto de Salud Pública (ISP), through its Agencia Nacional de Medicamentos (ANAMED), authorises manufacturers and verifies compliance with Norma Técnica N° 127.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.